belinostat

Trials studying belinostat

• phase3Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphomarecruitingn=150
• phase2Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanomaactive not recruitingn=7
• phase2Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCLrecruitingn=50
• phase3To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLrecruitingn=504
• phase1Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypescompletedn=17
• phase1Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomicsrecruitingn=34
• phase1Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancercompletedn=26